CA2836162A1 - Modularisation pour realisation et respect des ordonnances - Google Patents

Modularisation pour realisation et respect des ordonnances Download PDF

Info

Publication number: CA2836162A1
Authority: CA; Canada
Prior art keywords: patient; medication; prescription; module; medications
Prior art date: 2013-12-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA2836162A

Other languages

English (en)

Inventor

Patricia Crawford

Mark Maglione

Justin Towle

Thomas R. Grinnan

Sandra J. Eyerly

Frederick Thompson

Kenneth G. Sadler

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

WestRock MWV LLC

Original Assignee

Meadwestvaco Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2013-12-10

Filing date

2013-12-10

Publication date

2015-06-10

2013-12-10 Application filed by Meadwestvaco Corp filed Critical Meadwestvaco Corp

2013-12-10 Priority to CA2836162A priority Critical patent/CA2836162A1/fr

2015-06-10 Publication of CA2836162A1 publication Critical patent/CA2836162A1/fr

Status Abandoned legal-status Critical Current

Links

239000003814 drug Substances 0.000 claims abstract description 426
229940079593 drug Drugs 0.000 claims abstract description 426
238000002483 medication Methods 0.000 claims abstract description 152
230000000694 effects Effects 0.000 claims abstract description 70
230000006870 function Effects 0.000 claims abstract description 36
206010013710 Drug interaction Diseases 0.000 claims abstract description 5
238000000034 method Methods 0.000 claims description 90
230000004044 response Effects 0.000 claims description 65
238000004891 communication Methods 0.000 claims description 51
238000004519 manufacturing process Methods 0.000 claims description 12
230000008859 change Effects 0.000 claims description 7
238000012544 monitoring process Methods 0.000 claims description 4
230000000977 initiatory effect Effects 0.000 claims description 2
230000000295 complement effect Effects 0.000 abstract description 4
238000004806 packaging method and process Methods 0.000 description 45
230000001360 synchronised effect Effects 0.000 description 27
230000008569 process Effects 0.000 description 25
230000036541 health Effects 0.000 description 18
238000000275 quality assurance Methods 0.000 description 16
239000006187 pill Substances 0.000 description 14
238000003860 storage Methods 0.000 description 13
230000008901 benefit Effects 0.000 description 12
238000010586 diagram Methods 0.000 description 11
239000000945 filler Substances 0.000 description 11
238000007726 management method Methods 0.000 description 10
238000012552 review Methods 0.000 description 8
238000012937 correction Methods 0.000 description 7
230000003287 optical effect Effects 0.000 description 7
238000012545 processing Methods 0.000 description 7
201000010099 disease Diseases 0.000 description 6
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
239000000243 solution Substances 0.000 description 6
230000003442 weekly effect Effects 0.000 description 6
239000007788 liquid Substances 0.000 description 5
238000012986 modification Methods 0.000 description 5
230000004048 modification Effects 0.000 description 5
238000013515 script Methods 0.000 description 5
238000012546 transfer Methods 0.000 description 5
238000005429 filling process Methods 0.000 description 4
230000002093 peripheral effect Effects 0.000 description 4
238000002360 preparation method Methods 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 3
239000006071 cream Substances 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
230000003993 interaction Effects 0.000 description 3
230000006855 networking Effects 0.000 description 3
238000012015 optical character recognition Methods 0.000 description 3
230000002829 reductive effect Effects 0.000 description 3
239000007787 solid Substances 0.000 description 3
238000004448 titration Methods 0.000 description 3
238000013475 authorization Methods 0.000 description 2
230000009286 beneficial effect Effects 0.000 description 2
238000005352 clarification Methods 0.000 description 2
239000003086 colorant Substances 0.000 description 2
238000004590 computer program Methods 0.000 description 2
238000013500 data storage Methods 0.000 description 2
230000007547 defect Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000013461 design Methods 0.000 description 2
-1 effervescents Substances 0.000 description 2
238000007689 inspection Methods 0.000 description 2
210000004072 lung Anatomy 0.000 description 2
230000000474 nursing effect Effects 0.000 description 2
230000008520 organization Effects 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
230000003068 static effect Effects 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
238000012795 verification Methods 0.000 description 2
XMTQQYYKAHVGBJ-UHFFFAOYSA-N 3-(3,4-DICHLOROPHENYL)-1,1-DIMETHYLUREA Chemical compound CN(C)C(=O)NC1=CC=C(Cl)C(Cl)=C1 XMTQQYYKAHVGBJ-UHFFFAOYSA-N 0.000 description 1
241001556567 Acanthamoeba polyphaga mimivirus Species 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
206010061623 Adverse drug reaction Diseases 0.000 description 1
241001387976 Pera Species 0.000 description 1
230000004075 alteration Effects 0.000 description 1
239000003708 ampul Substances 0.000 description 1
108010038083 amyloid fibril protein AS-SAM Proteins 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000003287 bathing Methods 0.000 description 1
230000006399 behavior Effects 0.000 description 1
XMQFTWRPUQYINF-UHFFFAOYSA-N bensulfuron-methyl Chemical compound COC(=O)C1=CC=CC=C1CS(=O)(=O)NC(=O)NC1=NC(OC)=CC(OC)=N1 XMQFTWRPUQYINF-UHFFFAOYSA-N 0.000 description 1
230000002457 bidirectional effect Effects 0.000 description 1
230000033228 biological regulation Effects 0.000 description 1
235000021152 breakfast Nutrition 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000001768 cations Chemical class 0.000 description 1
238000000576 coating method Methods 0.000 description 1
231100000433 cytotoxic Toxicity 0.000 description 1
230000001472 cytotoxic effect Effects 0.000 description 1
230000007423 decrease Effects 0.000 description 1
TXFOLHZMICYNRM-UHFFFAOYSA-N dichlorophosphoryloxybenzene Chemical compound ClP(Cl)(=O)OC1=CC=CC=C1 TXFOLHZMICYNRM-UHFFFAOYSA-N 0.000 description 1
239000006196 drop Substances 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
239000005293 duran Substances 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000037406 food intake Effects 0.000 description 1
238000005242 forging Methods 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
238000001802 infusion Methods 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
238000002372 labelling Methods 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000006210 lotion Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
230000003340 mental effect Effects 0.000 description 1
239000000820 nonprescription drug Substances 0.000 description 1
238000009512 pharmaceutical packaging Methods 0.000 description 1
229920001690 polydopamine Polymers 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000012913 prioritisation Methods 0.000 description 1
238000012797 qualification Methods 0.000 description 1
238000011084 recovery Methods 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
210000001525 retina Anatomy 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000829 suppository Substances 0.000 description 1
238000012360 testing method Methods 0.000 description 1
230000000007 visual effect Effects 0.000 description 1
239000002699 waste material Substances 0.000 description 1

Classifications

- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H80/00—ICT specially adapted for facilitating communication between medical practitioners or patients, e.g. for collaborative diagnosis, therapy or health monitoring
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H15/00—ICT specially adapted for medical reports, e.g. generation or transmission thereof

Landscapes

Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Medical Informatics (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Primary Health Care (AREA)
Public Health (AREA)
Pathology (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Medical Treatment And Welfare Office Work (AREA)

CA2836162A 2013-12-10 2013-12-10 Modularisation pour realisation et respect des ordonnances Abandoned CA2836162A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA2836162A CA2836162A1 (fr)	2013-12-10	2013-12-10	Modularisation pour realisation et respect des ordonnances

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA2836162A CA2836162A1 (fr)	2013-12-10	2013-12-10	Modularisation pour realisation et respect des ordonnances

Publications (1)

Publication Number	Publication Date
CA2836162A1 true CA2836162A1 (fr)	2015-06-10

Family

ID=53365569

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2836162A Abandoned CA2836162A1 (fr)	2013-12-10	2013-12-10	Modularisation pour realisation et respect des ordonnances

Country Status (1)

Country	Link
CA (1)	CA2836162A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108492868A (zh) *	2018-03-06	2018-09-04	上海京颐科技股份有限公司	医疗移动终端及其功能模块控制方法、装置、存储介质
CN109544356A (zh) *	2018-10-23	2019-03-29	平安医疗健康管理股份有限公司	一种基于数据处理的风险检测方法、装置及存储介质
CN113903418A (zh) *	2021-09-15	2022-01-07	浙江大学	一种处方生成方法及装置
US11515023B2 (en)	2019-06-21	2022-11-29	Express Scripts Strategic Development, Inc.	Dynamic user interface generation for delivery scheduling optimization

2013
- 2013-12-10 CA CA2836162A patent/CA2836162A1/fr not_active Abandoned

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN108492868A (zh) *	2018-03-06	2018-09-04	上海京颐科技股份有限公司	医疗移动终端及其功能模块控制方法、装置、存储介质
CN109544356A (zh) *	2018-10-23	2019-03-29	平安医疗健康管理股份有限公司	一种基于数据处理的风险检测方法、装置及存储介质
CN109544356B (zh) *	2018-10-23	2023-10-20	平安医疗健康管理股份有限公司	一种基于数据处理的风险检测方法、装置及存储介质
US11515023B2 (en)	2019-06-21	2022-11-29	Express Scripts Strategic Development, Inc.	Dynamic user interface generation for delivery scheduling optimization
US12087420B2 (en)	2019-06-21	2024-09-10	Express Scripts Strategic Development, Inc.	Dynamic user interface generation for delivery scheduling optimization
CN113903418A (zh) *	2021-09-15	2022-01-07	浙江大学	一种处方生成方法及装置
CN113903418B (zh) *	2021-09-15	2024-09-06	浙江大学	一种处方生成方法及装置

Legal Events

Date	Code	Title	Description
2017-01-23	FZDE	Dead	Effective date: 20161212

Publication	Publication Date	Title
US20140156298A1 (en)	2014-06-05	Modularization for prescription fulfillment and adherence
US20140156064A1 (en)	2014-06-05	Techniques to deliver multiple medications in a synchronized manner
JP7381979B2 (ja)	2023-11-16	配薬支援システム
US11222714B2 (en)	2022-01-11	Method and apparatus for verification of medication adherence
US12243015B2 (en)	2025-03-04	System and method for automating pharmacy processing of electronic prescriptions
US10496796B2 (en)	2019-12-03	Monitoring medication adherence
US20050038558A1 (en)	2005-02-17	System and method for labeling pharmaceutical prescriptions
JP7421143B2 (ja)	2024-01-24	配薬支援システム
Berdot et al.	2019	Integration of a commercial barcode-assisted medication dispensing system in a teaching hospital
KR20250038195A (ko)	2025-03-19	의약품의 재고 관리를 위하여 정보를 처리하는 장치 및 그 방법
CA2836162A1 (fr)	2015-06-10	Modularisation pour realisation et respect des ordonnances
US20140114470A1 (en)	2014-04-24	Methods and systems for improving efficiency of pharmacy practice and reducing the incidence of medication errors
Cina et al.	2006	Medication errors in a pharmacy-based bar-code-repackaging center
TWM525508U (zh)	2016-07-11	醫療服務與管理系統
Barmecha et al.	2022	Medication Errors